Cite
Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer's disease continuum: considerations for clinical trials.
MLA
Scheijbeler, Elliz P., et al. “Longitudinal Resting-State EEG in Amyloid-Positive Patients along the Alzheimer’s Disease Continuum: Considerations for Clinical Trials.” Alzheimer’s Research & Therapy, vol. 15, no. 1, Oct. 2023, pp. 1–19. EBSCOhost, https://doi.org/10.1186/s13195-023-01327-1.
APA
Scheijbeler, E. P., de Haan, W., Stam, C. J., Twisk, J. W. R., & Gouw, A. A. (2023). Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer’s disease continuum: considerations for clinical trials. Alzheimer’s Research & Therapy, 15(1), 1–19. https://doi.org/10.1186/s13195-023-01327-1
Chicago
Scheijbeler, Elliz P., Willem de Haan, Cornelis J. Stam, Jos W. R. Twisk, and Alida A. Gouw. 2023. “Longitudinal Resting-State EEG in Amyloid-Positive Patients along the Alzheimer’s Disease Continuum: Considerations for Clinical Trials.” Alzheimer’s Research & Therapy 15 (1): 1–19. doi:10.1186/s13195-023-01327-1.